Epcoritamab with rituximab and lenalidomide for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6586]

In development
Reference number: GID-TA11768
Expected publication date: 03 September 2026

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 156 KB)

Published:

24 November 2025
Final stakeholder list (PDF 148 KB)

Published:

24 November 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 207 KB)

Published:

24 November 2025
Equality impact assessment (scoping) (PDF 108 KB)

Published:

24 November 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 165 KB)

Published:

18 September 2025
Provisional stakeholder list post referral (PDF 154 KB)

Published:

18 September 2025